Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Awareness and knowledge about cervical cancer prevention methods among Tunisian women.

Gamaoun R.

J Prev Med Hyg. 2018 Mar 30;59(1):E30-E35. doi: 10.15167/2421-4248/jpmh2018.59.1.709. eCollection 2018 Mar.

2.

A pilot study of oral S-1 for treating heavily pretreated patients with advanced or recurrent cervical cancer among Chinese population.

Ma L, Liu JM, Zhang J, Li H.

Medicine (Baltimore). 2018 Jun;97(22):e10922. doi: 10.1097/MD.0000000000010922.

3.

Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.

Gadducci A, Landoni F, Cosio S, Zizioli V, Zola P, Ferrero AM, Lapresa MT, Maggino T, Sartori E.

Anticancer Res. 2018 Jun;38(6):3627-3634. doi: 10.21873/anticanres.12637.

4.

Mitofusin-2 Expression Is Implicated in Cervical Cancer Pathogenesis.

Ahn SY, Li C, Zhang X, Hyun YM.

Anticancer Res. 2018 Jun;38(6):3419-3426. doi: 10.21873/anticanres.12610.

PMID:
29848692
5.

Does 100% Rapid Review Improve Cervical Cancer Screening?

Queiroz Filho J, Eleutério J Jr, Ney Cobucci R, de Oliveira Crispim JC, Giraldo PC, Gonçalves AK.

Acta Cytol. 2018;62(3):209-214. doi: 10.1159/000488872. Epub 2018 May 22.

PMID:
29788025
7.

Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.

Aoyama-Kikawa S, Fujita H, Hanley SJB, Kasamo M, Kikuchi K, Torigoe T, Matsuno Y, Tamakoshi A, Sasaki T, Matsuura M, Kato Y, Dong P, Watari H, Saito T, Sengoku K, Sakuragi N.

Cancer Sci. 2018 Jun;109(6):2003-2012. doi: 10.1111/cas.13608. Epub 2018 May 31.

8.

Cognitive predictors of cervical cancer screening's stages of change among sample of Iranian women health volunteers: A path analysis.

Miri MR, Moodi M, Sharif-Zadeh GR, Malaki Moghadam H, Miri M, Norozi E.

PLoS One. 2018 Mar 20;13(3):e0193638. doi: 10.1371/journal.pone.0193638. eCollection 2018.

9.

Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients.

Reisner SL, Deutsch MB, Peitzmeier SM, White Hughto JM, Cavanaugh TP, Pardee DJ, McLean SA, Panther LA, Gelman M, Mimiaga MJ, Potter JE.

PLoS One. 2018 Mar 14;13(3):e0190172. doi: 10.1371/journal.pone.0190172. eCollection 2018.

10.

HPV vaccination.

Dilley S, Miller K, Huh W.

Gynecol Oncol. 2018 Jan;148(1):3-4. doi: 10.1016/j.ygyno.2017.11.037. Epub 2017 Dec 12. No abstract available.

PMID:
29246414
11.

Motivating Mothers to Recommend Their 20-Year-Old Daughters Receive Cervical Cancer Screening: A Randomized Study.

Egawa-Takata T, Ueda Y, Morimoto A, Tanaka Y, Yagi A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, Okada H, Nakai H, Mandai M, Matsuzaki S, Kobayashi E, Yoshino K, Kimura T, Saito J, Hori Y, Morii E, Nakayama T, Asai-Sato M, Miyagi E, Sekine M, Enomoto T, Horikoshi Y, Takagi T, Shimura K.

J Epidemiol. 2018 Mar 5;28(3):156-160. doi: 10.2188/jea.JE20160155. Epub 2017 Nov 11.

12.

Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.

Allen-Leigh B, Uribe-Zúñiga P, León-Maldonado L, Brown BJ, Lörincz A, Salmeron J, Lazcano-Ponce E.

BMC Cancer. 2017 Nov 9;17(1):734. doi: 10.1186/s12885-017-3723-5.

13.
14.

Boosting workplace wellness programs with financial incentives.

Cuellar A, Haviland AM, Richards-Shubik S, LoSasso AT, Atwood A, Wolfendale H, Shah M, Volpp KG.

Am J Manag Care. 2017 Oct;23(10):604-610.

15.

Prevalence of Human Papillomavirus in Women from the State of Michoacan, Mexico, Showed High Frequency of Unusual Virus Genotypes.

Jácome-Galarza I, Ito-Nakashimada MA, Figueroa-Aguilar G, García-Latorre E, Salazar MI, López-Orduña E, Camacho AD, Valdez-Alarcón JJ, Hernández JM, León-Avila G.

Rev Invest Clin. 2017 Sep-Oct;69(5):262-269.

16.

Multimodal treatment including hysterectomy improves survival in patients with locally advanced cervical cancer: A population-based, propensity score-matched analysis.

Wu SG, Zhang WW, Sun JY, Li FY, He ZY, Zhou J.

Int J Surg. 2017 Dec;48:122-127. doi: 10.1016/j.ijsu.2017.10.028. Epub 2017 Oct 12.

PMID:
29032160
17.

Barriers to cervical cancer screening faced by immigrants: a registry-based study of 1.4 million women in Norway.

Leinonen MK, Campbell S, Ursin G, Tropé A, Nygård M.

Eur J Public Health. 2017 Oct 1;27(5):873-879. doi: 10.1093/eurpub/ckx093.

18.

Annual Report of the Committee on Gynecologic Oncology, Japan Society of Obstetrics and Gynecology: Patient Annual Report for 2014 and Treatment Annual Report for 2009.

Saito T, Takahashi F, Katabuchi H; 2016 Committee on Gynecologic Oncology of the Japan Society of Obstetrics and Gynecology.

J Obstet Gynaecol Res. 2017 Nov;43(11):1667-1677. doi: 10.1111/jog.13450. Epub 2017 Sep 11.

PMID:
28892220
19.

Surveillance of high-grade cervical cancer precursors (CIN III/AIS) in four population-based cancer registries, United States, 2009-2012.

Watson M, Soman A, Flagg EW, Unger E, Deapen D, Chen VW, Peres LC, Copeland G, Tucker TC, Garnett E, Saraiya M.

Prev Med. 2017 Oct;103:60-65. doi: 10.1016/j.ypmed.2017.07.027. Epub 2017 Jul 29.

20.

Expanded strain coverage for a highly successful public health tool: Prophylactic 9-valent human papillomavirus vaccine.

Zhang Z, Zhang J, Xia N, Zhao Q.

Hum Vaccin Immunother. 2017 Oct 3;13(10):2280-2291. doi: 10.1080/21645515.2017.1346755. Review.

Supplemental Content

Loading ...
Support Center